A new medical cannabis product is available in Peru. This move is the latest sign the cannabis market is moving in the right direction. Toronto-headquartered Khiron Life Sciences, a company with its main operations in Colombia, announced last Thursday it became the “first company to sell and fill medical cannabis prescriptions through private pharmacies in Peru.” With this new option, patients in Peru have access to two medicinal CBD products: One is imported from the United States and sold through a pharmacy owned and operated by the Peruvian General Directorate of Medicines, Supplies, and Drugs (DIGEMID) and the other is Khiron’s product imported from Colombia. The one offered by the DIGEMID pharmacy has a concentration of almost 5% CBD and is sold in 10-milliliter bottles for almost 48 soles ($13). No product with meaningful amounts of THC is currently available in the country. Cannabis insiders believe the biggest change in recent weeks has been, “the spike of new licenses to import and/or sell medical cannabis to patients.”

Marijuana Business Daily, 09/29/2020 15:23:34

Open article: https://mjbizdaily.com/new-cbd-product-available-under-prescription-in-peru/